about
Cancer cachexia--pathophysiology and managementNutrition in Patients with Gastric Cancer: An UpdateMolecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Cancer cachexia: impact, mechanisms and emerging treatmentsEicosapentaenoic acid and oxypurinol in the treatment of muscle wasting in a mouse model of cancer cachexiaMolecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.The altered tight junctions: an important gateway of bacterial translocation in cachexia patients with advanced gastric cancer.Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment1-Sarcosine-angiotensin II infusion effects on food intake, weight loss, energy expenditure, and skeletal muscle UCP3 gene expression in a rat modelThe Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma.Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile.Cancer cachexia, mechanism and treatmentGut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target.Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1.The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study.Health care professionals' experience, understanding and perception of need of advanced cancer patients with cachexia and their families: The benefits of a dedicated clinic.The effects of hospice-shared care for gastric cancer patients.Consilience in sarcopenia of cirrhosis.Efficacy of traditional Chinese medicine in treating cancer.Incidence and risk factor analysis for sarcopenia in patients with cancer.Differences in routine laboratory parameters related to cachexia between patients with hematological diseases and patients with solid tumors or heart failure - is there only one cachexia?Marine polyunsaturated fatty acids and cancer therapyPentoxifylline treatment in patients with cancer cachexia: A double-blind, randomized, placebo-controlled clinical trialMAP3K11/GDF15 axis is a critical driver of cancer cachexiaAn integrative and comparative study of pan-cancer transcriptomes reveals distinct cancer common and specific signatures.Mitofusin-2 prevents skeletal muscle wasting in cancer cachexia.Evaluation and correlation of serum lipid profile in oral and gastrointestinal cancer patients.Diet components associated with perceived fatigue in breast cancer survivors.Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice.Association between preoperative haemoglobin concentration and cardiopulmonary exercise variables: a multicentre study.Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan.Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia.The price of immunity.The role of dietary nutrition in stomach cancer.Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.Cachexia in patients with oesophageal cancer.Establishment and characterization of a novel murine model of pancreatic cancer cachexia.The Neurobiological Impact of Ghrelin Suppression after Oesophagectomy.Serum metabolic profiles reveal the effect of formoterol on cachexia in tumor-bearing mice.
P2860
Q24605567-954183BC-8A41-432D-AB17-975C358B4E5AQ26741105-EF4D6F1A-2957-4EE0-93F1-7C0698FE4597Q28068034-EFF78B36-E526-4D92-9873-67C58DC71788Q28384479-C9179770-E2B3-44FF-B1FA-BAEA9043A28AQ28483912-6540DFD9-F164-40FD-A8FE-1C03916B2176Q33624574-66BB0E3C-6089-48DB-891F-FD48C5C878EEQ33842314-F2E1BB3B-0387-4374-A0B3-9CDF60F50B4EQ33955139-D670CB79-D35D-471B-9AEC-40B31CE8FA35Q34156951-6AA52953-79C1-48E3-B83C-2A41B3FF98E5Q34506005-1E974EEA-6FAC-4804-892A-C1D90DE66DDCQ34590963-40AC8E15-46F9-41E4-9B49-5CC926C25546Q34669440-5026E462-8A61-48EE-8C2C-5570FEEE5A62Q35025946-785AB8EC-3C9C-43EB-927A-B0EB96936C54Q35341311-9025C444-EB9B-4FC0-9AA6-94A24086DDE4Q35850891-8135DBD7-A1EE-42F8-BCB4-41F742197E5DQ36225307-88A3C5C4-A06F-4C10-A90C-2C4468F7AA7AQ36236646-AFABAD6B-3D54-4985-9789-2A30BB656D12Q36269770-4AF771C4-EF1A-4C4B-93C6-198A9BCA11DAQ36421047-6FCDC7E2-86BB-489C-ABED-234C72DCCF17Q36502153-BFD61606-5E1E-480A-AB38-5CAD6383F200Q36524638-C01A51D4-0F32-457A-B48E-9ED4CCCC4C67Q36597318-AED8C90D-5870-4598-8F7C-71FC8FD625E3Q36671846-2FB8890E-2F89-496B-B9E3-91E36ADA5B59Q36801270-FF36AC4B-43DE-463D-8352-86CA1D62EF72Q36892019-727C6015-0D95-4DBB-97B6-8D5D738A61F0Q37260793-A81E4D41-56FA-49D3-BA16-B20CF05C33C8Q37407291-8CB32BC6-0FC1-4540-97B3-1A00B6333DBDQ37493407-4EBF8073-B7EF-49B1-A81C-FAF03F954135Q37587863-7B3E8526-271D-4F54-ABCD-7F1B8B40E29FQ37588336-120CDFEC-D6D7-4CD0-84F1-DE96721A18F4Q37660576-364FF8D9-BCFD-42E4-A1FC-333A0212B828Q37702050-613C2A51-08D7-4E82-BDD5-9A3E94BAA121Q37702064-EF71C438-F3CF-460E-877C-CB1E1A4A6CADQ38044667-6CB76FC2-5579-44F8-B5C7-87A492ED4AC6Q38193079-C05F6957-FB03-4AC9-BA26-FEA91E5153B0Q38462047-FF6E370F-73FE-4138-A443-127210B23012Q38634739-496C649B-EF0A-4819-856B-F69FDB8F1B2AQ38653925-3E8C9AF0-B4C3-406E-9AE6-EF8FDCA2CBF9Q39062975-6050CE61-103F-424B-9B1B-E6BD60FDD953Q39093151-202700B4-8F68-49EC-A392-5BAB4D1A9C9D
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cancer cachexia: mechanisms and clinical implications.
@ast
Cancer cachexia: mechanisms and clinical implications.
@en
Cancer cachexia: mechanisms and clinical implications.
@nl
type
label
Cancer cachexia: mechanisms and clinical implications.
@ast
Cancer cachexia: mechanisms and clinical implications.
@en
Cancer cachexia: mechanisms and clinical implications.
@nl
prefLabel
Cancer cachexia: mechanisms and clinical implications.
@ast
Cancer cachexia: mechanisms and clinical implications.
@en
Cancer cachexia: mechanisms and clinical implications.
@nl
P2860
P50
P356
P1476
Cancer cachexia: mechanisms and clinical implications.
@en
P2860
P304
P356
10.1155/2011/601434
P577
2011-06-13T00:00:00Z